Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
hMG
Description:
Human menopausal gonadotropin is a hormone preparation used in reproductive medicine to stimulate ovarian or testicular function.
Primary topic:
Reproductive Biology and Fertility (27%)
Related topics:
Reproductive Biology and Fertility (27%),
Reproductive Health and Technologies (21%),
Ovarian function and disorders (16%)
OpenAlex ID:
keywords/hmg
Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
2015
·
Yanping Kuang
, Qiuju Chen
, et al.
·
Fertility and Sterility
·
456
PDF
Predictive factors for pregnancy after intrauterine insemination (IUI): An analysis of 1038 cycles and a review of the literature
2008
·
Philippe Merviel
, Marie Hélène Heraud
, et al.
·
Fertility and Sterility
·
355
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)
2000
·
François Olivennes
, Joëlle Belaisch-Allart
, et al.
·
Fertility and Sterility
·
277
PDF
Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation
1997
·
Carola Albano
, Johan Smitz
, et al.
·
Fertility and Sterility
·
261
PDF
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles
2013
·
Yanping Kuang
, Qingqing Hong
, et al.
·
Fertility and Sterility
·
260
PDF
The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
1988
·
J. Smitz
, P. Devroey
, et al.
·
Human Reproduction
·
235
Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques
2004
·
Anna Pia Ferraretti
, Luca Gianaroli
, et al.
·
Fertility and Sterility
·
189
PDF
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles
2017
·
Sha Yu
, Hui Long
, et al.
·
Human Reproduction
·
169
PDF
Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics
2010
·
T. Adriaenssens
, S. Wathlet
, et al.
·
Human Reproduction
·
155
The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program
1994
·
François Olivennes
, Renato Fanchin
, et al.
·
Fertility and Sterility
·
154
Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination
2004
·
R. Wainer
, Martine Albert
, et al.
·
Human Reproduction
·
149
Analysis of factors influencing pregnancy rates in homologous intrauterine insemination
2004
·
Gilberto Ibérico
, Jesús Vioque
, et al.
·
Fertility and Sterility
·
149
Cessation of Gonadotropin-Releasing Hormone Agonist Therapy Combined with High-Dose Gonadotropin Stimulation Yields Favorable Pregnancy Results in Low Responders
1998
·
Barbara M Faber
, Jake Mayer
, et al.
·
Fertility and Sterility
·
148
PDF
Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels
1994
·
Dov Feldberg
, Jacob Farhi
, et al.
·
Fertility and Sterility
·
142
A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome
2001
·
Uma Deve Gordon
, Robert F Harrison
, et al.
·
Fertility and Sterility
·
127
Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy
1997
·
Renato Fanchin
, Claudia Righini
, et al.
·
Fertility and Sterility
·
123
PDF
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
2012
·
Maryam Eftekhar
, Abbas Aflatoonian
, et al.
·
Archives of Gynecology and Obstetrics
·
120
Hormonal Therapy of Male Hypogonadism
1994
·
Alvin M. Matsumoto
·
Endocrinology and Metabolism Clinics of North America
·
115
Sonographic uterine predictors of pregnancy in women undergoing ovulation induction for assisted reproductive treatments
1994
·
Paulo Serafini
, Joel Batzofin
, et al.
·
Fertility and Sterility
·
106
Cumulative conception rates following gonadotropin therapy
1980
·
Jehoshua Dor
, David J. Itzkowic
, et al.
·
American Journal of Obstetrics and Gynecology
·
95
Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF
2014
·
M. von Wolff
, Z. Kollmann
, et al.
·
Human Reproduction
·
94
PDF
Cost-effectiveness of infertility treatments: a cohort study
1997
·
Bradley J. Van Voorhis
, Amy E.T. Sparks
, et al.
·
Fertility and Sterility
·
94
PDF
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist
2016
·
Xuefeng Lu
, Qingqing Hong
, et al.
·
Fertility and Sterility
·
93
Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone
1995
·
F. Ubaldi
, J. Smitz
, et al.
·
Human Reproduction
·
92
Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility
2001
·
Dana A. Ohl
, Lynda J. Wolf
, et al.
·
Fertility and Sterility
·
91
Show more works
View as search
Works count:
734
Citation count:
9,915
Year
Topic
Type